Articles tagged "Kidney transplantation"

2021 American Transplant Congress
Poor Reliability of Karnofsky Performance Score in Kidney Transplant Candidates
M. R. Stedman, D. J. Watford, G. M. Chertow, J. C. Tan
Medicine, Stanford University, Palo Alto, CA
*Purpose: The Karnofsky Performance Status (KPS) Scale has been used as a proxy for frailty and as a predictor of transplant outcomes, however reliability of…
2021 American Transplant Congress
Patients’ Perceptions of Kidney Transplant Failure and Transitioning to Dialysis
E. Ramos¹, C. Gu², C. Hanson², K. Abdel-Kader³, K. Bonnet², D. Schlundt², E. Gordon⁴, B. P. Concepcion³
¹Cleveland Clinic Foundation, Cleveland, OH, ²Vanderbilt University, Nashville, TN, ³Vanderbilt University Medical Center, Nashville, TN, ⁴Northwestern University, Chicago, IL
*Purpose: Approximately 5,000 US kidney transplant recipients return to dialysis each year due to allograft failure. Understanding how kidney allograft failure and transitioning to chronic…
2021 American Transplant Congress
Deceased Donor Transplantation Across Positive Flow Crossmatch – A Single Center Experience
M. Campara, A. Lichvar, J. Benken, S. Patel, C. Muran, D. Pierce, I. Tang, P. Di Cocco, J. Almario Alvarez, M. Spaggiari, E. Benedetti, I. Tzvetanov
University of Illinois at Chicago, Chicago, IL
*Purpose: Transplantation across a positive flow crossmatch (+FXM) has been established as a lifesaving measure in the living donor setting. Time required for desensitization limits…
2021 American Transplant Congress
Obesity Impacts Acute Rejection but Not Allograft Function Improvement in the Setting of Belatacept Conversion
D. Pierce, J. Benken, P. West-Thielke, I. Tzvetanov, E. Benedetti, A. Lichvar
University of Illinois at Chicago, Chicago, IL
*Purpose: There is limited data regarding belatacept conversion in obese patients as an alternative to calcineurin inhibitor (CNI) immunosuppression. Pharmacokinetic (PK) data suggests increasing clearance…
2021 American Transplant Congress
Kidney Transplantation in Patients with Hereditary Kidney Diseases
Y. Caliskan¹, N. Garayeva², A. B. Dirim², S. Safak², S. Mirioglu², H. Yazici², A. Yildiz³, O. A. Oto², E. Demir², Y. Ozluk⁴, A. Turkmen², K. Lentine¹
¹Saint Louis University, Saint Louis, MO, ²Division of Nephrology, Istanbul University, Istanbul, Turkey, ³Division of Nephrology, Uludag University, Bursa, Turkey, ⁴Department of Pathology, Istanbul University, Istanbul, Turkey
*Purpose: Genetic testing is poised to play a larger role in the evaluation and management of both kidney transplant (KTx) recipients and donors. We characterized…
2021 American Transplant Congress
Initial Experiment of Self-expanding Metal Ureteral Stent in Recurrent Ureteral Stenosis After Kidney Transplantation
Q. Zhong, T. Song, J. Zeng, Y. Fan, X. Wei, T. Lin
Urology Institute and Organ Transplantation Center, West China Hospital, Chengdu, China
*Purpose: Expanding metal ureteral stent has been proven to be effective in the treatment of ureteral stenosis (US). However, its application in US after kidney…
2021 American Transplant Congress
Clinical Validation and Performance of Donor-Derived Cell-Free DNA in Allograft Rejection
S. Anand¹, A. Pai², J. S. Bromberg³, G. Gupta⁴, I. Moinuddin⁴, T. Alhamad⁵, V. Bowers⁶, S. Ghosh⁷, W. Tian⁷, L. Bu⁸, E. Stites⁹
¹Intermountain Medical Center, Murray, UT, ²University of Texas McGovern Medical School, Houston, TX, ³University of Maryland School of Medicine, Baltimore, MD, ⁴Virginia Commonwealth University, Richmond, VA, ⁵Washington University in St. Louis, St. Louis, MO, ⁶Tampa General Hospital, Tampa, FL, ⁷CareDx, Brisbane, CA, ⁸University of Minnesota, Minneapolis, MN, ⁹University of Colorado, Aurora, CO
*Purpose: Extensive literature regarding the utility of donor-derived cell-free DNA (dd-cfDNA) shares various thresholds for active rejection (AR) based on differing data sets for both…
2021 American Transplant Congress
Belatacept Conversion in Proteinuric Renal Transplant Recipients: An Interventional Multi-Center Trial
O. Efe¹, A. Al Jurdi¹, D. Wojciechowski², K. Safa¹, H. Gilligan¹, A. Chandraker³, J. Azzi³, A. Weins³, L. V. Riella¹
¹Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, ²UT Southwestern Medical Center, Dallas, TX, ³Brigham and Women’s Hospital, Boston, MA
*Purpose: Proteinuria develops in about 30% of kidney transplant recipients and is a strong predictor of graft loss. ACEis/ARBs can reduce proteinuria but are frequently…
2021 American Transplant Congress
I Would Do Whatever It Took”: Understanding the Motivation, Education and Experiences of Kidney Paired Donation Participants
R. Pines¹, Y. A. Iraheta², L. Ambriz², K. A. Dahmani², E. H. Wood², M. Cooper³, A. D. Waterman²
¹Santa Barbara Cottage Hospital, Santa Barbara, CA, ²UCLA David Geffen School of Medicine, Los Angeles, CA, ³Medstar Georgetown Transplant Institute, Washington, DC
*Purpose: To improve kidney paired donation (KPD) educational programs, we conducted semi-structured interviews to understand motivations of past recipients and donors to participate in KPD,…
2021 American Transplant Congress
Equity in Access to Kidney Transplants by Race/ethnicity in the Covid-19 Era
D. Stewart¹, A. Robinson², K. Bradbrook², A. Wilk², D. Klassen³
¹United Network for Organ Sharing, Richmond, VA, ²Research, United Network for Organ Sharing, Richmond, VA, ³Chief Medical Officer, United Network for Organ Sharing, Richmond, VA
*Purpose: The direct impact of the COVID-19 pandemic on minority populations has been well documented, and it is conceivable that disparities in access to kidney…